Evidence map›Paper›PMID 26536043›Full record

ArticleCancer2016

Variation in breast cancer care quality in New York and California based on race/ethnicity and Medicaid enrollment.

Michael J Hassett, Maria J Schymura, Kun Chen, Francis P Boscoe, Foster C Gesten, Deborah Schrag

Abstract readComparative Study
In one paragraph

Article in Cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Relationship between Insurance Type at Diagnosis and Hepatocellular Carcinoma Survival.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The Effects of Oncologist Implicit Racial Bias in Racially Discordant Oncology Interactions.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2016
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Michael J HassettDana-Farber Cancer Institute, Boston, Massachusetts.
Maria J SchymuraCancer Registry, New York State Department of Health, Albany, New York.
Kun ChenDana-Farber Cancer Institute, Boston, Massachusetts.
Francis P BoscoeCancer Registry, New York State Department of Health, Albany, New York.
Foster C GestenOffice of Quality and Patient Safety, New York State Department of Health, Albany, New York.
Deborah SchragDana-Farber Cancer Institute, Boston, Massachusetts.
Dana-Farber Cancer Institute · USNew York State Department of Health · US

Funding

Cancer Care Delivery in MedicaidR01CA131847 · NCI · DANA-FARBER CANCER INST · PI SCHRAG, DEBORAH · 2008 to 2012
$1.8M
Partnerships Between Medicaid, Tumor Registries & Cancer Control ResearchersK05CA169384 · NCI · DANA-FARBER CANCER INST · PI SCHRAG, DEBORAH · 2012 to 2016
$586k
NCI NIH HHS K05 CA169384NCI NIH HHS R01 CA131847NCI NIH HHS R01CA131847
6 · The paper itself

Abstract

backgroundRacial/ethnic and socioeconomic disparities persist in part because our current understanding of the care provided to minority and disadvantaged populations is limited. The authors evaluated the quality of breast cancer care in 2 large states to understand the disparities experienced by African Americans, Hispanics, Asian/Pacific Islanders (APIs), and Medicaid enrollees and to prioritize remediation strategies.

methodsStatewide cancer registry data for 80,436 women in New York and 121,233 women in California who were diagnosed during 2004 to 2009 with stage 0 through III breast cancer were used to assess underuse and overuse of surgery, radiation, chemotherapy, and hormone therapy based on 34 quality measures. Concordance values were compared across racial/ethnic and Medicaid-enrollment groups. Multivariable models were used to quantify disparities across groups for each treatment in each state.

resultsOverall concordance was 76% for underuse measures and 87% for overuse measures. The proportions of patients who received care concordant with all relevant measures were 35% in New York and 33% in California. Compared with whites, African Americans were less likely to receive recommended surgery, radiation, and hormone therapy; Hispanics and APIs were usually more likely to receive recommended chemotherapy. Across states, the same racial/ethnic groups did not always experience the same disparities. Medicaid enrollment was associated with decreased likelihood of receiving all recommended treatments, except chemotherapy, in both states. Overuse was evident for hormone therapy and axillary surgery but was not associated with race/ethnicity or Medicaid enrollment.

conclusionsPatient-level measures of quality identify substantial problems with care quality and meaningful disparities. Remediating these problems will require prioritizing low-performing measures and targeting high-risk populations, possibly in different ways for different regions.

Indexed as

MedicaidQuality of Health CareAdultAgedAsianBlack or African AmericanBreast NeoplasmsCaliforniaFemaleHealthcare DisparitiesHispanic or LatinoHumansMiddle AgedNative Hawaiian or Pacific IslanderNeoplasm GradingNeoplasm Stagingbreast cancerdisparitiesMedicaidquality

Identifiers

PMID26536043
PMCPMC4724235
OpenAlexW2119220122

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.